UK Markets closed

Neurocrine Biosciences, Inc. (0K6R.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
81.00+0.71 (+0.88%)
At close: 02:36PM GMT
Currency in USD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 0.77
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 381.00
52-week low 381.00
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 590.68M
Implied shares outstanding 6N/A
Float 893.26M
% held by insiders 11.34%
% held by institutions 1102.73%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)31 Mar 2021


Profit margin 38.45%
Operating margin (ttm)28.71%

Management effectiveness

Return on assets (ttm)11.69%
Return on equity (ttm)42.19%

Income statement

Revenue (ttm)1.05B
Revenue per share (ttm)11.18
Quarterly revenue growth (yoy)-0.20%
Gross profit (ttm)760.8M
Net income avi to common (ttm)402M
Diluted EPS (ttm)4.09
Quarterly earnings growth (yoy)-14.20%

Balance sheet

Total cash (mrq)873.7M
Total cash per share (mrq)9.24
Total debt (mrq)441.7M
Total debt/equity (mrq)36.64
Current ratio (mrq)5.71
Book value per share (mrq)12.76

Cash flow statement

Operating cash flow (ttm)280.3M
Levered free cash flow (ttm)324.59M